Thursday, April 20, 2017

No More ‘Superbugs’? Maple Syrup Extract Enhances Antibiotic Action

Newswise, April 20, 2017— Antibiotics save lives every day, but there is a downside to their ubiquity. High doses can kill healthy cells along with infection-causing bacteria, while also spurring the creation of “superbugs” that no longer respond to known antibiotics.

Now, researchers may have found a natural way to cut down on antibiotic use without sacrificing health: a maple syrup extract that dramatically increases the potency of these medicines.

The researchers will present their work at the 253rd National Meeting & Exposition of the American Chemical Society (ACS). ACS, the world’s largest scientific society, is holding the meeting here through Thursday. It features more than 14,000 presentations on a wide range of science topics.

“Native populations in Canada have long used maple syrup to fight infections,” says Nathalie Tufenkji, Ph.D. “I’ve always been interested in the science behind these folk medicines.”

The idea for the project really gelled when Tufenkji, who had been studying the antimicrobial effects of cranberry extracts, learned of the anti-cancer properties of a phenolic maple syrup extract.

“That gave me the idea to check its antimicrobial activity,” Tufenkji says. “So, I sent my postdoc to the store to buy some syrup.”

Using the same extraction approach as other researchers have in the past, Tufenkji’s team at McGill University separated the sugar and water from the syrup’s phenolic compounds, which contribute to maple syrup’s signature golden hue.

In an initial test, the team exposed several disease-causing bacterial strains to the extract, but they didn’t see much of an effect. Rather than give up on maple syrup altogether, Tufenkji decided to check whether the extract could enhance the antimicrobial potency of the commonly used antibiotics ciprofloxacin and carbenicillin.

When her team mixed the phenolic extract with either of these medicines, they indeed found a synergistic effect, allowing them to get the same antimicrobial effect with upwards of 90 percent less antibiotic.

The approach worked on a variety of bacterial strains, including E. coli, which can cause gastrointestinal problems; Proteus mirabilis, responsible for many urinary tract infections; and Pseudomonas aeruginosa, which can cause infections often acquired by patients in hospitals.

Building on this work, Tufenkji’s team next tested the extract in fruit flies and moth larvae. The researchers dosed fly food with pathogenic bacteria and antibiotic, with and without the phenolic extract.

Flies with meals doused in maple syrup extract lived for days longer than those denied the syrupy topper. The researchers observed a similar outcome with the moth larvae.

To figure out how the extract makes antibiotics work better, the researchers investigated whether the extract changed the permeability of bacterial cells. The extract increased the permeability of the bacteria, suggesting that it helps antibiotics gain access to the interior of bacterial cells.

Another experiment suggested that the extract may work by a second mechanism as well, disabling the bacterial pump that normally removes antibiotics from these cells.

Currently, the researchers are testing the maple syrup extract in mice. While it is likely to be years before it would be available to patients as a prescribed medical protocol, and a pharmaceutical company would likely need to purify the extract further to avoid any potential allergic reactions, Tufenkji says, she’s hopeful that it may have an edge over other would-be medications thanks to its source.

“There are other products out there that boost antibiotic strength, but this may be the only one that comes from nature,” she says.

Tufenkji acknowledges funding from Canada Research Chairs, the Natural Sciences and Engineering Research Council of Canada and the William and Rhea Seath Award at McGill University.


The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With nearly 157,000 members, ACS is the world’s largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

Monday, April 3, 2017

New Measurement Technique Lowers Estimated Vitamin D Recommended Daily Allowance




Recommended daily allowance for Vitamin D lowered
Newswise, April 3, 2017After re-measurement of vitamin D by improved technology, the Recommended Dietary Allowance (RDA) for vitamin D intake drops from 800 to 400 International Units (IU) per day, new research reports. The results of the study were presented at the annual scientific meeting of the Endocrine Society, in Orlando, Fla.

"The RDA is easily achievable with a supplement of 400 IU in winter, when vitamin D levels are lowest in North America," said principal investigator J. Christopher Gallagher, M.D., professor and director of the Bone Metabolism Unit in the Division of Endocrinology of Creighton University School of Medicine in Omaha, Neb.

"This has important ramifications for public health recommendations. The amount of vitamin D needed, 400 IU daily, is less than the figure recommended by Institute of Medicine," said Gallagher, the study's principal investigator.

"In estimating the RDA for vitamin D intake, the laboratory method used for measuring serum 25-hydroxyvitamin D ̶ 25(OH)D ̶ can affect the results," he said. "The estimated RDA based on the older immunoassay (DiaSorin S.p.A., Salugia, Italy) system was 800 IU daily, whereas the newer liquid chromatography tandem-mass spectrometry (LC-MS/MS) technique estimated that 400 IU daily would meet the RDA."

In their earlier double-blind dose-response clinical trial in the winter and spring of 2007 to 2008, Gallagher and his colleagues enrolled 163 healthy postmenopausal Caucasian women 57 through 90 years of age with vitamin D insufficiency and followed them for 1 year.

The women were at least 7 years postmenopausal and they had vitamin D insufficiency based on the World Health Organization cutoff (serum 25(OH)D 20 ng/ml or lower).

The participants were randomized to one of seven vitamin D3 doses: 400, 800, 1600, 2400, 3200, 4000, 4800 IU/day or placebo, for 1 year, and all the women were given calcium supplements to maintain a total calcium intake.

After analyzing the samples and estimating the RDA using the older immunoassay, the authors reported that 800 IU daily would meet the vitamin D intake requirement for 97.5 percent of the population.

But now that liquid chromatography mass spectrometry (LC-MS/MS) has become the gold standard for measuring 25(OH)D, the researchers have reanalyzed the original samples using this new technology.

Able to determine a more precise dose-response curve, they have calculated the RDA for vitamin D to be 400 IU daily.

"Remember, this RDA is for bone health only," Gallagher cautioned. "It may be different for other diseases. Although trials looking into cancer, diabetes, and other diseases are ongoing, we do not have information about this yet."